Association of K-ras Mutational Status and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Receiving Panitumumab Alone-Reference-Cited by-同舟云学术

Association of K-ras Mutational Status and Clinical Outcomes in Patients with Metastatic Colorectal Cancer Receiving Panitumumab Alone

Published:2008-05 Issue:3 Volume:7 Page:184-190
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Freeman Daniel J.,Juan Todd,Reiner Maureen,Hecht J. Randolph,Meropol Neal J.,Berlin Jordan,Mitchell Edith,Sarosi Ildiko,Radinsky Robert,Amado Rafael G.

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference42 articles.

1. ras oncogenes in human cancer: a review;Bos;Cancer Res,1989

2. Prevalence of ras gene mutations in human colorectal cancers;Bos;Nature,1987

3. K-ras and p16 aberrations confer poor prognosis in human colorectal cancer;Esteller;J Clin Oncol,2001

4. Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab;Ince;J Natl Cancer Inst,2005

5. Kirsten ras mutations in patients with colorectal cancer: the “RASCAL II” study;Andreyev;Br J Cancer,2001

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and characterization of anti-G12V mutated K-Ras monoclonal antibodies using hybridoma technology;Asia Pacific Journal of Molecular Biology and Biotechnology;2023-12-02

2. Mutational profile of KRAS, NRAS, BRAF, PIK3CA, and AKT1 genes in colorectal cancer patients in a tertiary care hospital, Dhaka;Advances in Cancer Biology - Metastasis;2022-10

3. Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the REVOLT study;Journal of Geriatric Oncology;2021-10

4. Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines;Annals of Oncology;2021-08

5. Biomarker testing and mutation prevalence in metastatic colorectal cancer patients in five European countries using a large oncology database;Future Oncology;2021-04